| Mrs Jennifer P Berry, NP | |
|
105 Spanish Ct, Albany, GA 31707-1282 | |
| (229) 438-7100 | |
| (229) 438-9382 |
| Full Name | Mrs Jennifer P Berry |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 105 Spanish Ct, Albany, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447489117 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN164502 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy And Asthma Clinics Of Ga | 1052305919 | 6 |
News Archive
Consistent resin performance and the retention of physical and mechanical properties over a wide range of conditions are critical to plastic medical devices. Bayer MaterialScience LLC scientists have studied newly introduced medical grades of its Makrolon® polycarbonate resin to demonstrate how these grades maintain stiffness, toughness and other key properties after gamma sterilization.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.
Olympic Gold Medalist Peggy Fleming and the P.A.D. Coalition want to help educate women and their families about an often times silent cardiovascular disease, peripheral arterial disease.
› Verified 7 days ago
| Entity Name | Phoebe Putney Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992789721 PECOS PAC ID: 4486559549 Enrollment ID: O20031203000397 |
News Archive
Consistent resin performance and the retention of physical and mechanical properties over a wide range of conditions are critical to plastic medical devices. Bayer MaterialScience LLC scientists have studied newly introduced medical grades of its Makrolon® polycarbonate resin to demonstrate how these grades maintain stiffness, toughness and other key properties after gamma sterilization.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.
Olympic Gold Medalist Peggy Fleming and the P.A.D. Coalition want to help educate women and their families about an often times silent cardiovascular disease, peripheral arterial disease.
› Verified 7 days ago
| Entity Name | Allergy & Asthma Clinics Of Ga |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093997447 PECOS PAC ID: 1052305919 Enrollment ID: O20040413000951 |
News Archive
Consistent resin performance and the retention of physical and mechanical properties over a wide range of conditions are critical to plastic medical devices. Bayer MaterialScience LLC scientists have studied newly introduced medical grades of its Makrolon® polycarbonate resin to demonstrate how these grades maintain stiffness, toughness and other key properties after gamma sterilization.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.
Olympic Gold Medalist Peggy Fleming and the P.A.D. Coalition want to help educate women and their families about an often times silent cardiovascular disease, peripheral arterial disease.
› Verified 7 days ago
| Entity Name | Phoebe Sumter Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609001312 PECOS PAC ID: 4385789213 Enrollment ID: O20110324000491 |
News Archive
Consistent resin performance and the retention of physical and mechanical properties over a wide range of conditions are critical to plastic medical devices. Bayer MaterialScience LLC scientists have studied newly introduced medical grades of its Makrolon® polycarbonate resin to demonstrate how these grades maintain stiffness, toughness and other key properties after gamma sterilization.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.
Olympic Gold Medalist Peggy Fleming and the P.A.D. Coalition want to help educate women and their families about an often times silent cardiovascular disease, peripheral arterial disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer P Berry, NP 105 Spanish Ct, Albany, GA 31707-1282 Ph: (229) 438-7100 | Mrs Jennifer P Berry, NP 105 Spanish Ct, Albany, GA 31707-1282 Ph: (229) 438-7100 |
News Archive
Consistent resin performance and the retention of physical and mechanical properties over a wide range of conditions are critical to plastic medical devices. Bayer MaterialScience LLC scientists have studied newly introduced medical grades of its Makrolon® polycarbonate resin to demonstrate how these grades maintain stiffness, toughness and other key properties after gamma sterilization.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.
Olympic Gold Medalist Peggy Fleming and the P.A.D. Coalition want to help educate women and their families about an often times silent cardiovascular disease, peripheral arterial disease.
› Verified 7 days ago
Israel Saucedo, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-312-1000 | |
Brittany Pines, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 425 W 3rd Ave, Suite 105, Albany, GA 31701 Phone: 229-312-2380 | |
Rhonda Jeannean Haynes, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 204 N Westover Blvd, Albany, GA 31707 Phone: 229-888-6559 Fax: 229-436-4107 | |
Scarlett Ann Wade, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 414 5th Ave, Albany, GA 31701 Phone: 229-883-4555 Fax: 229-888-0063 | |
Josiane K Ewiah, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 417 W 4th Ave, Albany, GA 31701 Phone: 229-312-1000 | |
Susan Darlene Boyett, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2402 Osler Ct, Albany, GA 31707 Phone: 229-438-3300 Fax: 229-438-4651 | |
Ms. Beverly Ann Willis, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2000 Palmyra Rd, Albany, GA 31701 Phone: 229-434-2173 Fax: 229-434-2548 |